Lyophilized Peptide Storage: Temperature, Light and Stability

A lyophilized peptide looks inert: a small white cake at the bottom of a vial. It is not. Water, heat, oxygen and light keep working on it, slowly in the solid state and much faster once it is dissolved. Good lyophilized peptide storage is about slowing those reactions enough that the material you assay in month six is the material described on the certificate. This guide explains the degradation chemistry, then turns it into practical rules for temperature, moisture, light and handling, with Epithalon and BPC-157 as sequence-specific examples.

Why freeze-drying helps, and where it stops helping

Lyophilization removes water by freezing a solution and subliming the ice under vacuum. The dry solid is far more stable than the solution because most degradation pathways need water or molecular mobility. Reviews of solid protein formulation make two points that apply equally to peptides [2]. First, the drying process itself imposes freezing and dehydration stresses. Second, even a well-made lyophilizate has finite stability, governed largely by residual moisture and storage temperature relative to the glass transition of the solid.

Put simply: the drier and colder the cake, the less its molecules can move, and the slower they react. A lyophilized peptide that picks up moisture loses much of that advantage.

The chemistry of peptide degradation

The main pathways are well characterized in the protein-stability literature [1, 4]:

• Deamidation and isomerization. Asparagine side chains can attack the adjacent backbone to form a cyclic succinimide, which then opens to aspartate or isoaspartate. Aspartate follows a similar route to isoaspartate. Model peptide studies showed that an Asn-Gly sequence deamidated with a half-life of only 1.4 days at 37 C and pH 7.4 [3]. Glycine after Asn or Asp is the fastest context because it offers no steric hindrance.
• Oxidation. Methionine converts to methionine sulfoxide (+16 Da), cysteine forms disulfides or higher oxides, and tryptophan, histidine and tyrosine are susceptible to oxidative and light-driven reactions [4].
• Cyclization. N-terminal glutamine or glutamate can form pyroglutamate; N-terminal dipeptides can cyclize to diketopiperazines and cleave off [4].
• Hydrolysis. Peptide bonds adjacent to aspartate are relatively labile, particularly at acidic pH.
• Aggregation and adsorption. Hydrophobic sequences can self-associate in solution, and peptides can adsorb to vial surfaces. One study measured an average 10% loss of five model peptides during a drying step and found the loss depended on vial material and additives [5].

All of these proceed faster in solution than in the dry state, and faster warm than cold.

Lyophilized peptide storage temperatures

Condition	Typical use for lyophilized peptide
-80 C	Long-term archive, reference lots
-20 C	Routine long-term storage
2-8 C	Short-term holding, days to weeks
Room temperature	Transit and brief handling only

Most short, stable sequences tolerate ambient shipping for days because the solid is dry and reactions are slow. That tolerance does not extend to months on a bench. Frost-free freezers are worth avoiding for archives: their defrost warming swings expose samples to repeated small temperature excursions.

Moisture, light and oxygen

Moisture: the most underrated variable

Lyophilized peptides are hygroscopic, and TFA or acetate salts make them more so. Three habits keep water out:

1. Warm before opening. Let a vial reach room temperature in a desiccator, typically 20-30 minutes, before breaking the seal. Opening it cold draws condensation onto the cake.
2. Weigh fast and reseal. Minimize time open to air; purge the headspace with dry nitrogen or argon if the peptide contains oxidation-prone residues.
3. Store with desiccant. A sealed secondary container with silica gel buffers against freezer humidity.

Light and oxygen

Photo-oxidation mainly threatens tryptophan, tyrosine, histidine and methionine. Amber vials or foil wrap and storage in the dark are simple precautions. For cysteine- or methionine-containing sequences, an inert-gas overlay limits oxygen exposure and reduces disulfide scrambling and sulfoxide formation.

Sequence-specific examples: Epithalon and BPC-157

Reading a sequence for liabilities is the fastest way to decide how cautious to be.

Epithalon is the tetrapeptide Ala-Glu-Asp-Gly (AEDG, 390.35 Da), the compound used in cell-culture studies of telomerase activity in human fetal fibroblasts [6]. It has no methionine, cysteine or tryptophan, so oxidation is a minor concern. Its C-terminal Asp-Gly, however, is the textbook motif for succinimide formation and isoaspartate generation [3]. Isoaspartate has the same mass as aspartate, so the change is invisible to a simple mass check and shows up instead as a closely eluting HPLC peak. For AEDG, keeping the solid dry and solutions short-lived matters more than light protection.

BPC-157 is a 15-residue sequence (GEPPPGKPADDAGLV) that also lacks Met, Cys, Trp and Asn. Its liabilities are the Asp-Asp and Asp-Ala bonds, which are candidates for acid-catalysed cleavage and isomerization in solution. Four prolines give it a relatively rigid backbone. In practice it is a comparatively robust solid, but the same rules apply: cold, dry, sealed.

Handling once a peptide is in solution

Solution handling is covered in detail in our post on reconstitution solvents for peptide research, but the storage principles are short:

• Aliquot on first dissolution. Divide the stock into single-use volumes so each tube is thawed once. Repeated freezing and thawing promotes aggregation and concentrates solutes at ice interfaces [1].
• Control pH. Many peptides are most stable between pH 5 and 6; deamidation generally accelerates at neutral to basic pH [1].
• Choose low-binding tubes for dilute stocks, where surface adsorption is a larger fraction of the total [5].
• Record everything. Label aliquots with the lot number, concentration and date. Our post on lot numbers and traceability explains why that link back to the source vial matters when data need to be reconciled later.

Checking stability over time

Storage conditions are an assumption until the material is re-tested. For peptides held many months, or used as a reference lot, a periodic HPLC run against the original chromatogram is the simplest check. Each degradation route leaves a recognisable signature:

• Deamidation adds about 1 Da and usually produces a new peak eluting close to the main one.
• Isoaspartate formation leaves the mass unchanged but often appears as a shoulder or partly resolved peak.
• Oxidation adds 16 Da per oxygen and typically shifts retention earlier on reversed-phase columns.
• Aggregation may show up as broadened peaks, lost area or visible turbidity after dissolution.

Comparing a new chromatogram and mass spectrum with the lot's original data, such as the reports posted on our lab reports page, shows whether a stored sample still matches its certificate.

Key takeaways

• Lyophilized peptides are stable, not immortal. Water, heat, oxygen and light still drive degradation.
• Store at -20 C (or -80 C for archives), sealed, desiccated and dark; use 2-8 C only for short periods.
• Warm vials to room temperature before opening to prevent condensation.
• Read the sequence for liabilities: Asn/Asp-Gly for succinimide chemistry, Met/Cys/Trp for oxidation, N-terminal Gln for pyroglutamate.
• Aliquot solutions once, avoid repeated freezing and thawing, and track each aliquot to its lot.

This article summarizes published research for informational purposes. All Ascent Sciences products are for laboratory research use only and are not for human or animal consumption.

References

1. Manning MC, Chou DK, Murphy BM, et al. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. PubMed
2. Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. 2000;203(1-2):1-60. PubMed
3. Geiger T, Clarke S. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. J Biol Chem. 1987;262(2):785-794. PubMed
4. Grassi L, Cabrele C. Susceptibility of protein therapeutics to spontaneous chemical modifications by oxidation, cyclization, and elimination reactions. Amino Acids. 2019;51(10-12):1409-1431. PubMed
5. Pezeshki A, Vergote V, Van Dorpe S, et al. Adsorption of peptides at the sample drying step: influence of solvent evaporation technique, vial material and solution additive. J Pharm Biomed Anal. 2009;49(3):607-612. PubMed
6. Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003;135(6):590-592. PubMed